The company continues to lean on customers’ appetite for apps and services, as demand for its devices weakens.
OpenAI and the FDA are reportedly discussing AI for drug evaluations
- today, 5:09 PM
- techcrunch.com
- 0

The company continues to lean on customers’ appetite for apps and services, as demand for its devices weakens.
No comments